何氏眼科
(301103)
| 流通市值：20.46亿 | | | 总市值：38.91亿 |
| 流通股本：8309.01万 | | | 总股本：1.58亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 284,795,525.11 | 1,185,231,535.43 | 944,181,578.16 | 620,995,594.44 |
| 营业收入 | 284,795,525.11 | 1,185,231,535.43 | 944,181,578.16 | 620,995,594.44 |
| 二、营业总成本 | 246,017,043.14 | 1,086,814,283.25 | 797,898,549.34 | 511,996,840.09 |
| 营业成本 | 160,247,293.04 | 690,284,215.83 | 524,706,314.57 | 341,762,982.65 |
| 税金及附加 | 1,319,692.15 | 7,025,090.81 | 4,153,731.09 | 2,331,585.11 |
| 销售费用 | 39,004,361.4 | 177,973,546.11 | 125,457,084.93 | 78,031,673.84 |
| 管理费用 | 48,914,804.77 | 214,304,385.81 | 149,800,984.65 | 96,268,350.59 |
| 研发费用 | 2,428,194.82 | 12,623,576.49 | 7,865,450.18 | 3,445,781.54 |
| 财务费用 | -5,897,303.04 | -15,396,531.8 | -14,085,016.08 | -9,843,533.64 |
| 其中:利息费用 | 2,879,392.79 | 13,603,417.08 | 9,465,191.21 | 5,976,929.43 |
| 其中:利息收入 | 9,433,029.62 | 31,751,488.43 | 25,774,748.67 | 17,222,395.62 |
| 加:投资收益 | - | 3,167,739.49 | 2,530,245.54 | 2,578,630.14 |
| 资产处置收益 | 23,186.09 | 3,528,059.24 | -133,085.17 | -110,141.24 |
| 资产减值损失(新) | -1,175,567.71 | -1,215,692.79 | -1,539,335.06 | -759,468.52 |
| 信用减值损失(新) | -1,023,178.52 | -2,488,987.94 | -1,750,622.41 | -1,781,629.57 |
| 其他收益 | 1,380,323.13 | 5,253,561.43 | 3,476,519.99 | 2,312,695.2 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 37,983,244.96 | 106,661,931.61 | 148,866,751.71 | 111,238,840.36 |
| 加:营业外收入 | 15,785.84 | 843,186.04 | 502,605.76 | 245,652.99 |
| 减:营业外支出 | 201,775.77 | 2,125,005.23 | 1,802,687.79 | 306,469.75 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 37,797,255.03 | 105,380,112.42 | 147,566,669.68 | 111,178,023.6 |
| 减:所得税费用 | 10,614,924.08 | 47,590,126.93 | 51,436,739.98 | 34,525,894.63 |
| 六、净利润 | 27,182,330.95 | 57,789,985.49 | 96,129,929.7 | 76,652,128.97 |
| 持续经营净利润 | 27,182,330.95 | 57,789,985.49 | 96,129,929.7 | 76,652,128.97 |
| 归属于母公司股东的净利润 | 28,976,245.02 | 63,551,557.35 | 99,410,544.63 | 78,347,857.61 |
| 少数股东损益 | -1,793,914.07 | -5,761,571.86 | -3,280,614.93 | -1,695,728.64 |
| (一)基本每股收益 | 0.18 | 0.4 | 0.63 | 0.5 |
| (二)稀释每股收益 | 0.18 | 0.4 | 0.63 | 0.5 |
| 八、其他综合收益 | -58.02 | 787.59 | 3,392.72 | 4,947.91 |
| 归属于母公司股东的其他综合收益 | -58.02 | 787.59 | 3,392.72 | 4,947.91 |
| 九、综合收益总额 | 27,182,272.93 | 57,790,773.08 | 96,133,322.42 | 76,657,076.88 |
| 归属于母公司股东的综合收益总额 | 28,976,187 | 63,552,344.94 | 99,413,937.35 | 78,352,805.52 |
| 归属于少数股东的综合收益总额 | -1,793,914.07 | -5,761,571.86 | -3,280,614.93 | -1,695,728.64 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-28 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |